Sleep Health News
-
Showcase
AARP Names Its Innovator in Aging Prize Winner
En español | A wristband that helps you cool off or warm up quickly, offering relief from hot flashes or increasing your comfort, won AARP’s Innovator in Aging prize Tuesday morning. AARP CEO Jo Ann Jenkins presented the award to the company, Embr Labs, for its Wave device during a live segment on Good Morning America. The advocacy group for older adults increasingly is looking to ...
By Aidar Health
-
Showcase
AARP Names Its Innovator in Aging Prize Winner
En español | A wristband that helps you cool off or warm up quickly, offering relief from hot flashes or increasing your comfort, won AARP’s Innovator in Aging prize Tuesday morning. AARP CEO Jo Ann Jenkins presented the award to the company, Embr Labs, for its Wave device during a live segment on Good Morning America. The advocacy group for older adults increasingly is looking to ...
By Aidar Health
-
MedSource Labs Corporate Wellness Tips: Digital Detox and Screen Time Management
In today’s digital age and remote work environments, the boundaries between work and personal life have become increasingly blurred. With the prevalence in our lives of smartphones, tablets, and laptops, employees are spending more time in front of screens than ever before. As executives, it’s our responsibility to recognize the impact of excessive screen time on our ...
-
NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players
NHL Alumni Association (NHLAA), NEEKA Health Canada("NEEKA"),and CanaQuest Medical Corp ("CanaQuest") are pleased to announce a transformative study partnership that will investigate the efficacy of Mentanine® as a potential treatment to reduce anxiety in former NHL ...
-
BioXcel Therapeutics Announces First Patients Dosed in SERENITY III Phase 3 Trial for Acute Treatment of Agitation in Adults with Bipolar I or II Disorder or Schizophrenia
SERENITY III will evaluate the efficacy and safety of BXCL501 for at-home use Top-line pivotal data expected in 1H 2023 Estimated 23 million annual agitation episodes in the home-setting would more than double current market opportunity for BXCL501 in the U.S. 1-4 BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop ...
-
Creative Enzymes Expands Its Probiotic Portfolio
Creative Enzymes, a professional enzyme provider located in New York, USA, is always hammering away at research and trials in order to provide customers with enzyme services and products with its greatest effort. With the continuous expansion of business areas and scales, the company has set foot in other areas, established a sound probiotic production and supply chain, and is pleased to announce ...
-
Bayer expands development program for elinzanetant with Phase III study in breast cancer patients with vasomotor symptoms caused by endocrine therapy
Study plans to investigate elinzanetant as non-hormonal treatment for vasomotor symptoms caused by endocrine therapy in breast cancer patients Elinzanetant is an innovative non-hormonal development compound in development for the treatment of vasomotor symptoms during menopause Bayer, a global leader in women’s healthcare, announced today that it expands the Phase III clinical ...
By Bayer AG
-
Signifier Medical Technologies Announces Publication of Peer-Reviewed Analysis Demonstrating Improvement in Obstructive Sleep Apnea Severity with Neuromuscular Electrical Stimulation
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announced that a peer-reviewed paper has recently been published in Sleep and Breathing. The analysis, published by University of California San Diego investigators Dr. Brandon Nokes, Professor Atul Malhotra, and other collaborators, is based on a post-hoc analysis ...
-
Signifier Medical Technologies’ eXciteOSA®, the only FDA-authorized daytime therapy for primary snoring and mild obstructive sleep apnea, demonstrates real-world adherence to treatment of over 80%
Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announced today the results of an analysis of real-world patient adherence data for its lead product, eXciteOSA. The data demonstrated that real-world patients in the US prescribed eXciteOSA, the first daytime therapy indicated to treat primary snoring and mild ...
-
A Guide to Dental Oral Surgeries
Oral surgeons have the skillset and the technology to transform their patients’ mouths. From relatively simple tasks like removing impacted teeth to life-saving measures like removing oral cancer, these highly skilled professionals are trained to rescue their patients in their time of need. There’s more than one way to get your teeth worked on. Dental surgeries come in many ...
-
Who can benefit from an adjustable gastric band implant?
Who can benefit from an adjustable gastric band implant? Adults between the ages of 18 and 60 years with morbid obesity (BMI of > 40) or severe obesity (BMI of > 35) with at least one complication (diabetes, hypertension, sleep apnea syndrome, joint disorders) People who have already tried to lose weight without success despite receiving specialized medical care for several months ...
-
Research from Beacon Biosignals Presented at Alzheimer`s Association International Conference
Beacon Biosignals, a startup that applies AI to EEG to unlock precision medicine for neurological and psychiatric disorders, presented research at the Alzheimer's Association International Conference, which took place July 31–Aug. 4, 2022, in San Diego. Medical Director Jay Pathmanathan, MD, PhD, discussed how the company has applied its machine learning platform to standard ...
-
BioSerenity, Inc. appoints new leadership in North America
BioSerenity, a high-growth company specializing in research and remote diagnostic solutions for neurology, sleep medicine, and cardiology, announces Jeff Wren’s appointment as Chief Executive Officer of North America. Jeff Wren assumes the leadership role in the states as Pierre Frouin, CEO of BioSerenity, moves back to Europe. Since its expansion to the United States in 2019, ...
By BioSerenity
-
SoeMac user testimonials - better breathing
We’re always pleased to receive a testimonial from any of our SoeMac users. Here are just a few shared recently with us by people who have found that SoeMac helps them to breathe more easily. Celia - Breathing Neil, thankyou so much for servicing my SoeMac. I received it back this morning and will clean it regularly as per the instructions. I am so grateful, SoeMac has really helped with ...
By SoeMac
-
Neurolief Announces Exclusive Licensing Agreement with NeuroFront for Development and Commercialization of Relivion in Greater China and South Korea
Neurolief, an Israel-based company pioneering neuromodulation for the treatment of chronic neurological and neuropsychiatric disorders, and NeuroFront, a clinical stage biotech company focusing on innovative neuroscience therapies, jointly announced an exclusive licensing agreement for NeuroFront to develop and commercialize Relivion, non-invasive medical devices for the treatment of migraine and ...
-
Bodyport Appoints John Lipman as Chief Executive Officer
Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, today announced the appointment of medtech industry veteran, John Lipman, as Chief Executive Officer. Bodyport co-founder, Corey Centen, will continue as President and also serve as Chief Technology Officer (CTO) of the company. Lipman’s appointment comes as Bodyport prepares for ...
-
PepsinCheck: A Direct-to-Consumer Reflux Test for U.S. Consumers
Restech is proud to announce the launch of PepsinCheck, a PEPTEST product branded for the U.S. consumer market. New at-home reflux test can be ordered online at www.pepsincheck.com UK healthcare innovator, RD Biomed, developed Peptest, the world’s first non-invasive test for reflux, in 2007. Since that time it has grown to global prominence. Shipping costs and wait times were a barrier ...
By Restech
-
Saluda Medical Announces Robust Scientific Presence at 2022 International Neuromodulation Society (INS) World Congress
Key data highlights with the Evoke® System to include holistic composite treatment outcomes for disrupting the chronic pain cycle; opioid-sparing effects of therapy; real-world results; and cost-effectiveness compared to open-loop stimulation. Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an ...
-
Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize INBRIJA in Latin America
Acorda Therapeutics, Inc. (Nasdaq: ACOR) and Biopas Laboratories today announced that they have entered into distribution and supply agreements to commercialize INBRIJA in Latin America. INBRIJA is indicated in the United States for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson's disease (PD) treated with a levodopa/dopa-decarboxylase ...
-
Medimprove – A New Private Clinic For Lung Revalidation With FRI
To address the need for better chronic respiratory care, Prof De Backer, emeritus Professor Pulmonology at the University of Antwerp and Chairman of The board of FLUIDDA NV, has opened a private clinic in Belgium near the Fluidda headquarters in Kontich, Belgium. The clinic uses a multidisciplinary approach for chronic respiratory failure. Care at this private clinic can involve exercise ...
By Fluidda
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you